What are the recommended treatment options for a woman with polycystic ovary syndrome?

Treatment of Polycystic Ovary Syndrome

Lifestyle modification with weight loss of at least 5% of initial body weight is the foundational first-line treatment for all women with PCOS, regardless of fertility goals, as it improves metabolic, reproductive, and hormonal outcomes. 1

Initial Management: Lifestyle Intervention

Weight loss is the priority intervention for women with PCOS who are overweight or obese, as even modest weight reduction (5% of initial body weight) improves ovulation rates, pregnancy outcomes, insulin sensitivity, and androgen levels. 1

• Multicomponent lifestyle programs combining dietary modification, exercise, and behavioral strategies should be implemented before or alongside pharmacotherapy. 1
• Exercise programs provide metabolic benefits even without weight loss and should be recommended universally. 1
• High-protein diets are not specifically recommended due to concerns about adverse effects on renal function and lipids. 1

For Women NOT Seeking Pregnancy

Menstrual Regulation and Hyperandrogenism

Combined oral contraceptive pills (OCPs) are first-line pharmacotherapy for menstrual irregularity, hirsutism, and acne in women not attempting conception. 1, 2

• OCPs suppress ovarian androgen secretion and increase sex hormone-binding globulin levels. 1
• Low-dose formulations are preferred. 3
• OCPs reduce endometrial cancer risk, though the magnitude of this benefit in PCOS specifically is unknown. 1
• Despite increasing triglycerides and HDL cholesterol, no evidence shows increased cardiovascular events with OCP use in PCOS compared to the general population. 1

For hirsutism specifically, combined medical therapy is most effective:

• Combination of an antiandrogen (spironolactone, flutamide, or finasteride) plus an OCP provides superior results to either agent alone. 1
• Topical eflornithine hydrochloride cream is the only FDA-approved agent specifically for hirsutism treatment. 1
• Mechanical hair removal (laser, electrolysis) should be combined with medical androgen suppression for optimal results. 1

Metabolic Management

Metformin is first-line pharmacotherapy for metabolic manifestations including insulin resistance and prevention of type 2 diabetes. 1, 2

• Metformin improves or stabilizes glucose tolerance over time in women with PCOS. 1
• Metformin may have positive impact on cardiovascular risk factors, though its role in primary/secondary prevention of cardiovascular disease remains uncertain. 1
• Thiazolidinediones (pioglitazone, rosiglitazone) improve insulin sensitivity but tend to increase weight, whereas metformin tends to decrease weight. 1
• Note: No insulin-sensitizing agent is FDA-approved specifically for PCOS treatment. 1

All women with PCOS require metabolic screening:

• Screen for type 2 diabetes with fasting glucose followed by 2-hour glucose after 75-gram oral glucose load at diagnosis and periodically thereafter. 1
• Screen for dyslipidemia with fasting lipid panel (total cholesterol, LDL, HDL, triglycerides) at diagnosis and annually. 1

For Women Seeking Pregnancy

Ovulation Induction Algorithm

Step 1: Lifestyle modification with weight control and regular exercise as initial therapy. 1

Step 2: Clomiphene citrate is first-line pharmacotherapy for ovulation induction based on strong evidence of effectiveness. 1

• Approximately 80% of women with PCOS ovulate with clomiphene, and 50% of those who ovulate conceive. 1
• Letrozole (an aromatase inhibitor) can also be used as first-line therapy for ovulation induction. 4, 2

Step 3: If clomiphene fails, use low-dose gonadotropin therapy as second-line treatment. 1

• Low-dose protocols induce high rates of monofollicular development with lower risk of ovarian hyperstimulation syndrome compared to high-dose regimens. 1

Alternative Step 3: Laparoscopic ovarian drilling can be considered as second-line therapy, though its benefit and role remain undetermined. 1, 4

Metformin and thiazolidinediones improve ovulation frequency but have uncertain effects on early pregnancy outcomes. 1

• Metformin appears safe in pregnancy, but documentation is limited. 1
• Metformin alone has limited benefits for improving live birth rates. 4

Bariatric Surgery

Bariatric surgery can be considered when BMI ≥35 kg/m² and lifestyle therapy has failed, primarily for general health benefits. 4

In Vitro Fertilization

IVF is indicated for women who fail lifestyle modification and ovulation induction, or who have additional infertility factors. 4

• GnRH antagonist protocols are safer than agonist protocols in PCOS. 4
• If GnRH agonist protocol is used, metformin as adjunct may reduce ovarian hyperstimulation syndrome risk. 4

Critical Screening and Monitoring

Screen all women with PCOS for:

• Type 2 diabetes at diagnosis with fasting glucose and 2-hour oral glucose tolerance test. 1
• Dyslipidemia at diagnosis and annually with complete fasting lipid panel. 1
• Depression and anxiety, which are highly prevalent in PCOS. 3, 5

Important Caveats

• Avoid using polycystic ovarian morphology on ultrasound or anti-Müllerian hormone levels for diagnosis in adolescents. 3
• Patients should be counseled about potential side effects of ovulation induction agents, risks of multiple pregnancy, and increased maternal/fetal risks during pregnancy, particularly when obesity is present. 4
• Weight stigma should be minimized when discussing weight-related health risks. 3
• Acupuncture and herbal mixtures lack clear evidence for efficacy in PCOS. 4